Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation – (Engage Af – Timi 48 Trial): Primary Results - European Medical Journal

Continue

Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation – (Engage Af – Timi 48 Trial): Primary Results

Cardiology
Download PDF
Speaker:
Robert Giugliano

Associate Professor of Medicine, Harvard Medical School, Cambridge, Massachusetts, USA

Citation:
EMJ Cardiol. ;[1](Suppl 1):6-7. DOI/10.33590/emjcardiol/10310135. https://doi.org/10.33590/emjcardiol/10310135.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

The following is an executive summary of the abstract presentation by Prof Robert Giugliano on the ENGAGE AF – TIMI 48 trial primary results. It was presented on 19th November 2013 at the American Heart Association (AHA) annual congress, held in Dallas, Texas.

Please view the full content in the pdf above.

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.

Thank you!

Please share some more information on the rating you have given